Skip to main content
Top
Published in: Diabetologia 6/2008

Open Access 01-06-2008 | Research Letter

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

Authors: M. Nieuwdorp, M. Vergeer, R. J. Bisoendial, J. op ‘t Roodt, H. Levels, R. S. Birjmohun, J. A. Kuivenhoven, R. Basser, T. J. Rabelink, J. J. P. Kastelein, E. S. G. Stroes

Published in: Diabetologia | Issue 6/2008

Login to get access

Excerpt

To the Editor: HDL-cholesterol is inversely correlated with cardiovascular events in all major epidemiological studies [1]. HDL-increasing strategies have demonstrated that HDL-cholesterol increase is associated with decreased cardiovascular risk in high-risk individuals such as patients with type 2 diabetes [2]. Endothelial dysfunction, a hallmark of type 2 diabetes patients, has been shown to predict future cardiovascular events [3]. Therefore, we investigated the effect of reconstituted HDL (rHDL) on endothelial function measured both acutely (4 h after infusion) and 7 days after infusion in type 2 diabetes patients. Control volunteers were measured only at baseline and 4 h after infusion. …
Literature
1.
go back to reference Turner RC, Millns H, Neil HA et al (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 316:823–828PubMed Turner RC, Millns H, Neil HA et al (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 316:823–828PubMed
2.
go back to reference Keech A, Simes RJ, Barter P et al (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366:1849–1861PubMedCrossRef Keech A, Simes RJ, Barter P et al (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366:1849–1861PubMedCrossRef
3.
go back to reference Rohrer L, Hersberger M, von Eckardstein A (2004) High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15:269–278PubMedCrossRef Rohrer L, Hersberger M, von Eckardstein A (2004) High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15:269–278PubMedCrossRef
4.
go back to reference Bisoendial RJ, Hovingh GK, Levels JH (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107:2944–2948PubMedCrossRef Bisoendial RJ, Hovingh GK, Levels JH (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107:2944–2948PubMedCrossRef
5.
go back to reference van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ (2002) Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45:1004–1010PubMedCrossRef van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ (2002) Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45:1004–1010PubMedCrossRef
6.
go back to reference Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS (1999) Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84:3212–3216PubMedCrossRef Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS (1999) Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84:3212–3216PubMedCrossRef
7.
go back to reference Isomaa B, Almgren P, Tuomi T et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689PubMedCrossRef Isomaa B, Almgren P, Tuomi T et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689PubMedCrossRef
8.
go back to reference Singh IM, Shishehbor MH, Ansell BJ (2007) High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298:786–798PubMedCrossRef Singh IM, Shishehbor MH, Ansell BJ (2007) High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298:786–798PubMedCrossRef
Metadata
Title
Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus
Authors
M. Nieuwdorp
M. Vergeer
R. J. Bisoendial
J. op ‘t Roodt
H. Levels
R. S. Birjmohun
J. A. Kuivenhoven
R. Basser
T. J. Rabelink
J. J. P. Kastelein
E. S. G. Stroes
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0975-2

Other articles of this Issue 6/2008

Diabetologia 6/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.